Shane Fejfar, MD
Orthopaedic Surgery · Manhattan, KSNPI 1669437695
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Stryker at 39.7% of the total. 2025 is the largest year on record at $203, 2.8 times the $72 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in KS, where the typical reported total is $3,614.
Across 24 payments — averaging $24.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$237
- Smith+Nephew$77
- Kerecis Limited$45
- Acumed LLC$42
- Titan Surgical Group, LLC$37
- Treace Medical Concepts, Inc.$27
- plus $131 from 7 others
What the payments were for
- Food & beverage$598100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 6 | $237 |
| Smith+Nephew | 4 | $77 |
| Kerecis Limited | 2 | $45 |
| Acumed LLC | 1 | $42 |
| Titan Surgical Group, LLC | 2 | $37 |
| Treace Medical Concepts, Inc. | 1 | $27 |
| Medacta USA, Inc. | 2 | $26 |
| Aesculap, Inc. | 1 | $25 |
| Convatec Inc. | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Solventum Corporation | 1 | $15 |
| Sonex Health, Inc. | 1 | $13 |
| AbbVie | 1 | $12 |
How this compares
$598 in reported general payments places this provider in the 20th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 27 | $284 |
| Methylprednisolone | 20 | $161 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $135 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Manhattan
- Nicholas DuethmanManhattan$57K
- Timothy CareyManhattan$38K
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
- Jacob DeisterTopeka$185K
- Harold EllsworthLeawood$154K
- Tyler BronWichita$107K
- William ReedLenexa$106K
- Alexander BaileyOverland Park$99K
- Brent WiseKansas City$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.